Health
Mutation-signature–associated metrics predict cancer progression in patients – News-Medical.Net
Oncotarget published “Predicting clinical outcomes using cancer progression associated signatures” which reported somatic mutation…

Oncotarget published “Predicting clinical outcomes using cancer progression associated signatures” which reported somatic mutation signatures are an informative facet of cancer etiology, however they are rarely useful for predicting patient outcome.
The…
Continue Reading
-
Business20 hours ago
Macquarie tips 14% upside for this ASX tech stock
-
Noosa News16 hours ago
William Robinson dies aged 89
-
Business18 hours ago
Top brokers name 3 ASX shares to buy today 27 August 2025
-
Business20 hours ago
This ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.